FABP4 and Insulin resistance: Plasminogen activator inhibitor (PAI)-1, Adiponectin, retinol-binding protein-4 (RBP4), chemerin, and adipocyte fatty-acid-binding protein (A-FABP) have been suggested as potential biomarkers for insulin resistance.